Riverside Partners is an American investment firm, specializing in private equity, based in Boston. Riverside Partners develops and manages private equity investment products in middle market healthcare and technology companies. Founded in 1989, Riverside Partners has managed more than $700 million in investments in over 55 companies. The firm is currently focused on companies with revenues between $20 –$200 million and with $5 – $25 million of EBITDA.
Investment funds
Between 1988 and 2011, Riverside Partners has developed five funds investing more than $1 billion in targeted healthcare technology companies. Riverside Fund I, LP (closed) Riverside Fund II, LP (closed) Riverside Fund III, LP (closed) Riverside Fund IV, LP (closed) – $406,000,000 Riverside Fund V, LP (closed) - $561,000,000
Investments
Riverside Partners’ investments in medical device, software and technology companies include more than a dozen current engagement and nine closed sales. Applied Precision (acquired) Barrier Safe Solutions International (acquired) Cushcraft (acquired) MicroCal (acquired) MicroDental (acquired) Quantum Medical Imaging (acquired) Rudolph Technologies, Inc. (IPO) Vocollect (acquired) Dominion Diagnostics Eliassen GEM Engineering Health Drive IPA ITC Global Logically Max Vision NDS Surgical Imaging Pilgrim Software Real Goods Solar Tech Valley Communications Tegra Medical Thinklogical Weblocalize